The Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) is a NIH funded multi-site study focused on early-onset Alzheimer's Disease #LEADS

Joined September 2019
Check out these poster presentations from the #LEADS study at the #AAIC23
4
477
Do not miss these oral presentations from the #LEADS study. #AAIC23
5
10
923
LEADS poster presentations at the AIC #AAIC23
2
469
Do not miss the Annual NIA-AA Precision Medicine symposium featuring major research initiatives including @LEADS_study, AMP-AD, @Model_ad_alz, TREAT-AD, AGMP, ABC-DS, HABLE, and many more. Expect to hear a lot of cutting-edge science. shorturl.at/evBY6
9
13
Is LEADS the next frontier for clinical trials? Do not miss the Day 1 #CTAD2020 keynote by @ApostolovaLiana. @DrMariaALZ @HeatherAlz @RabLab_UCSF @DickersonLabMGH @IUMedSchool @NeurosciStark @CTADconference @grinberg_t @DrNeuroChic
3
1
15
CONGRATULATIONS to @DrMariaALZ who received the prestigious Lifetime Achievement Award in AD therapeutic Research today at #CTAD2020.
1
1
22
Taking care of Judy Carter-Oram (age 59), in the condition she’s in, is challenging and heartbreaking. I hope that no one reading this ever has to go through this with your spouse - although, if there’s not a cure for Alzheimer’s SOON, many of you will! Patrick Oram
1
2
#AAIC2020 Thank you LEADS Featured Topics Session presenters for a job well done! For those who missed the live session tune in tomorrow for an on-demand recording. @ApostolovaLiana @grinberg_t @DrMariaALZ @DickersonLabMGH @RabLab_UCSF
1
3
1
26
Our virtual LEADS Investigators meeting with nearly 130 participants all over the US was a success. COVID-19 or not,we are committed to advancing the science on EOAD! #ENDALZ @ApostolovaLiana @DrMariaALZ @RabLab_UCSF @IUMedSchool @DrNeuroChic @grinberg_t @ATRI_USC @NeurosciStark
1
23
LEADS PI @ApostolovaLiana on the set of WISH-TV promoting LEADS during Alzheimer's Awareness month #ENDALZ #leads
1
9
LEADS leadership met with industry+academic @alzassociation Research Roundtable members to discuss two future initiatives - international expansion (iLEADS) and clinical trials (iLEADS-TU). We are excited about these new opportunities. @ApostolovaLiana @DrMariaALZ #ENDALZ
1
2
13